Rita Thakkar serves as Chief Accounting Officer at MADRIGAL PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Rita Thakkar has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 15, 2026 involved receiving (via award) 1,826 shares valued at $0.
Rita Thakkar currently holds 1,826 shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL), valued at approximately $0. This represents their equity stake as Chief Accounting Officer.
Based on SEC Form 4 filings, Rita Thakkar has been a net neutral trader of MDGL stock. They have purchased $0 and sold $0 worth of shares.
Rita Thakkar's most recent insider trade was on Jan 15, 2026, when they sold 1,826 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |